Clinical Trial Update: A Study of Arzoxifene to Treat Korean Women With Osteoporosis [Phase 2]

View source ↗

Summary

A Phase 2 study of arzoxifene for osteoporosis in Korean women has completed. The sponsor is Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Arzoxifene (arzoxifene)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED